Summary
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.
How Congress Voted
House — Mar 23, 2026
149 votes
141(95%)
Yea
0(0%)
Nay
0(0%)
Present
8(5%)
Not voting
Related bills
Legislative Journey
- Introduced
- Committee
- Floor
- Passed Chamber 1
- Passed Chamber 2
- Signed
Jan 27, 2025
REFERRED TO HEALTH
HouseMar 12, 2025
AMEND (T) AND RECOMMIT TO HEALTH
HouseMar 12, 2025
PRINT NUMBER 3283A
HouseJan 7, 2026
REFERRED TO HEALTH
HouseFeb 23, 2026
AMEND AND RECOMMIT TO HEALTH
HouseFeb 23, 2026
PRINT NUMBER 3283B
HouseMar 12, 2026
AMEND AND RECOMMIT TO HEALTH
HouseMar 12, 2026
PRINT NUMBER 3283C
HouseMar 17, 2026
REPORTED
HouseMar 19, 2026
ADVANCED TO THIRD READING CAL.315
HouseMar 23, 2026
PASSED ASSEMBLY
HouseMar 23, 2026
DELIVERED TO SENATE
HouseMar 23, 2026
REFERRED TO HEALTH
Senate